Cases analyzed for CBL mutations
| Disease category . | Cases analyzed . | Cases with CBL variants . |
|---|---|---|
| PV | 74 | 0 |
| MF | 53 | 3 (6%) |
| ET | 24 | 0 |
| SM | 60 | 0 |
| CMML | 78 | 10 (13%) |
| aCML | 152 | 12 (8%) |
| HES/CEL | 96 | 1 (1%) |
| CNL | 9 | 0 |
| CML-BC | 31 | 0 |
| Total | 577 |
| Disease category . | Cases analyzed . | Cases with CBL variants . |
|---|---|---|
| PV | 74 | 0 |
| MF | 53 | 3 (6%) |
| ET | 24 | 0 |
| SM | 60 | 0 |
| CMML | 78 | 10 (13%) |
| aCML | 152 | 12 (8%) |
| HES/CEL | 96 | 1 (1%) |
| CNL | 9 | 0 |
| CML-BC | 31 | 0 |
| Total | 577 |
PV indicates polycythemia vera; MF, myelofibrosis; ET, essential thrombocythemia; SM, systemic mastocytosis; CMML, chronic myelomonocytic leukemia; aCML, atypical chronic myeloid leukemia; HES/CEL, hypereosinophilic syndrome/chronic eosinophilic leukemia; CNL, chronic neutrophilic leukemia; and CML-BC, CML in transformation to blast crisis.